Levetiracetam Hikma (levetiracetam): Reviews and patient testimonials
Back to the list of medications
Medication indications
Levetiracetam Hikma 100 mg/ml concentrate for solution for infusion
Levetiracetam is indicated as monotherapy in the treatment of partial onset seizures with or without secondary generalisation in adults and adolescents from 16 years of age with newly diagnosed epilepsy.
Levetiracetam is indicated as adjunctive therapy
• in the treatment of partial onset seizures with or without secondary generalisation in adults, adolescents and children from 4 years of age with epilepsy.
• in the treatment of myoclonic seizures in adults and adolescents from 12 years of age with Juvenile Myoclonic Epilepsy.
• in the treatment of primary generalised tonic-clonic seizures in adults and adolescents from 12 years of age with Idiopathic Generalised Epilepsy.
Levetiracetam concentrate for solution for infusion is an alternative for patients when oral administration is temporarily not feasible.
Route of administration: Injectable
Molecule: levetiracetam
Tips and advice of the community
Join Carenity and be the first to give your opinion on this medication.